Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

30,000 HIV patients enrolled in massive french observational study

NCT ID NCT02898987

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is a long-term project that collects health information from 30,000 HIV patients at 15 clinics in France. The goal is to track how well HIV treatments are working, monitor changes in the disease over time, and understand related health issues like hepatitis C. No new treatments are being tested—instead, researchers are observing routine care to improve future patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 30,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2016

Expected to finish

Jan 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All HIV-infected patients seeking care at 15 centers using NADIS are included in the Dataids cohort after receiving oral information and giving written consent. NADIS is an electronic medical record (EMR) for HIV-, hepatitis B virus (HBV)- or hepatitis C virus (HCV)-infected adults seeking care in French public hospitals. The Dataids study recruits HIV-1 positive patients above the age of 18 years. Approximately 30 % of the patients are women. The study does not intervene with the clinical management of the patients followed, but only collects information from patient records.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * HIV-1 infected patients regardless of CD4 cell count and antiretroviral therapy status Exclusion Criteria: * Patients under 18 years of age * Patients without written informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    38 sites in 3 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Study site

    RECRUITING

    Faye-l'Abbesse, France

  • CH Bretagne-Atlantique

    RECRUITING

    Vannes, France

  • CH Nîmes

    RECRUITING

    Nîmes, France

  • CH Rochefort

    RECRUITING

    Rochefort, France

  • CH Troyes

    RECRUITING

    Troyes, France

  • CHD Vendée

    RECRUITING

    La Roche-sur-Yon, France

  • CHIC

    RECRUITING

    Créteil, France

  • CHIV

    RECRUITING

    Villeneuve-Saint-Georges, France

  • CHR Metz-Thionville

    RECRUITING

    Metz, France

  • CHR Orléans

    RECRUITING

    Orléans, France

  • CHRU Brest

    RECRUITING

    Brest, France

  • CHU Besançon - Hôpital Jean Minjoz

    RECRUITING

    Besançon, France

  • CHU Clermont-Ferrand - Hôpital Gabriel-Montpied

    RECRUITING

    Clermont-Ferrand, France

  • CHU Limoges

    RECRUITING

    Limoges, France

  • CHU Nancy - Hôpital Brabois

    RECRUITING

    Nancy, France

  • CHU Nantes - Hôtel-Dieu

    RECRUITING

    Nantes, France

  • CHU Nice

    RECRUITING

    Nice, France

  • CHU Reims - Hôpital Robert Debré

    RECRUITING

    Reims, France

  • CHU Rennes - Hôpital Pontchaillou

    RECRUITING

    Rennes, France

  • CHU Rouen

    RECRUITING

    Rouen, France

  • CHU St Etienne - Hôpital Nord

    RECRUITING

    Saint-Etienne, France

  • CHU Strasbourg - Hôpital Civil

    RECRUITING

    Strasbourg, France

  • CHU Toulouse - Hôpital Purpan

    RECRUITING

    Toulouse, France

  • CHU Tourcoing - Hôpital Guy Chatiliez

    RECRUITING

    Tourcoing, France

  • CHU de Guadeloupe

    RECRUITING

    Pointe-à-Pitre, Guadeloupe

  • CHU de Martinique

    RECRUITING

    Fort-de-France, Martinique

  • Centre Hospitalier de Brive

    RECRUITING

    Brive-la-Gaillarde, France

  • Centre Hospitalier de Cornouaille

    RECRUITING

    Quimper, France

  • Centre Hospitalier de La Rochelle

    RECRUITING

    La Rochelle, France

  • Centre Hospitalier de Niort

    RECRUITING

    Niort, France

  • Groupe Hospitalier Pitié Salpêtrière - Assistance Publique des Hôpitaux de Paris

    RECRUITING

    Paris, France

  • Hôpital Bichat - Assistance Publique des Hôpitaux de Paris

    RECRUITING

    Paris, France

  • Hôpital Bicêtre - Assistance Publique des Hôpitaux de Paris

    RECRUITING

    Le Kremlin-Bicêtre, France

  • Hôpital Gui de Chauliac

    RECRUITING

    Montpellier, France

  • Hôpital Necker-Pasteur - Assistance Publique des Hôpitaux de Paris

    RECRUITING

    Paris, France

  • Hôpital Nord Franche Comté

    RECRUITING

    Belfort, France

  • Hôpital Sainte Marguerite - Assistance Publique des Hôpitaux de Marseille

    RECRUITING

    Marseille, France

  • Hôpital de la Croix-Rousse - Hospices Civils de Lyon

    RECRUITING

    Lyon, France

  • IHU - Assistance Publique des Hôpitaux de Marseille

    RECRUITING

    Marseille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.